Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
PIRAMAL PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   PCE(x) 22.4916.66--

What is the latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA is 22.49 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202422.49
Mar202316.66
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of PIRAMAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 22.49
34.99
Mar2023 16.66
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹26,610.6 Cr -5.1% -4% 27.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-5.1%

-4%

27.3%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses